Global Metagenomics Market to 2025 - Emergence of New Fields in Genomics that Complement Metagenomics
DUBLIN, Oct. 29, 2018 /PRNewswire/ --
The "Metagenomics Market Size, Share & Trends Analysis Report By Product (Sequencing & Data Analytics), By Technology (Sequencing, Function), By Application (Environmental), And Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.
The global metagenomics market size is expected to reach USD 1.40 billion by 2025, exhibiting a CAGR of 16.6% during the forecast period.
Rise in demand for microbial screening in food and chemical industries for commercial applications, coupled with rapid developments in bioinformatics and biotechnology tools, is anticipated to accelerate market growth in the coming years.
Key market participants are striving to capitalize potential avenues in the market by addressing challenges faced by research entities pertaining to data assembly, identification, and verification of rare metagenomes. Furthermore, companies operating in the molecular diagnostics and genomics arena are a playing crucial role in this market by partnering with metagenomics companies for development of novel tests for disease diagnosis.
For instance, in September 2017, IDbyDNA, Inc. and ARUP Laboratories co-developed Explify Respiratory-a metagenomic NGS test for screening of respiratory infections. The anticipated launch of many such novel tests is projected to boost the market during the forecast period.
Further key findings from the report suggest:
- Kits and reagents formed the largest segment by product in 2017 owing to frequent usage at various steps in microbial genomic studies
- Surplus growth in genomics database with respect to types and numbers has led to rising demand for better data analysis solutions. As a result, the sequencing and data analytics services segment is expected to emerge as a lucrative source of revenue generation during the forecast period
- Function driven technology held the major revenue share in 2017. Development of new screening procedures that facilitate rapid screening of large clone libraries has enabled functional detection of novel enzymes from metagenomes
- Advancements in genetic tools have broadened the application scope of metagenomics to include targeting microbes responsible for inducing various cancer forms. This, in turn, is driving the application of metagenomic analysis in human health
- North America dominated the market in 2017. Strong presence of key NGS leaders like Illumina and a substantial number of ongoing genomics-related studies in U.S. are major factors contributing to its large share
- Some of the key competitors in the market are Illumina, Inc.; Promega Corporation; Novogene Corporation; Oxford Gene Technology, Inc.; Thermo Fisher Scientific, Inc.; TAKARA BIO INC.; Danaher; QIAGEN; and ELITechGroup
- Acquisition of small players with a strong product portfolio is a prominently adopted strategy by dominant players. For instance, in August 2016, Perkin Elmer acquired Bio Scientific Corporation-provider of 16S & 18S library preparation kits for metagenome studies
- Competitors are also involved in collaborations with bioinformatics companies for co-development of novel platforms for metagenomics analysis.
Key Topics Covered:
Chapter 1 Executive Summary
1.1 Market Snapshot
Chapter 2 Research Methodology
2.1 Information Procurement
2.1.1 Purchased database:
2.1.2 Internal database
2.2 Information or Data Analysis
2.3 Market Formulation & Validation
2.4 Approaches for Market Estimation
2.4.1 Approach 1: Commodity flow & bottom up approach
2.4.2 Approach 2: Top down and parent market analysis
Chapter 3 Metagenomics Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market driver analysis
3.1.1.1 Declining expenses of sequencing
3.1.1.1.1 Decline in cost of per genome sequencing 2010 to 2016
3.1.1.1.2 Decline in cost of per Megabase DNA sequencing 2010 to 2016
3.1.1.2 Developments in biotechnology & bioinformatics techniques
3.1.1.3 Interest in microbial screening for different investigations
3.1.1.3.1 Number of metagenomics studies registered in Integrated Microbial Genomes & Microbiomes (IMG/M) web server 2017
3.1.1.4 Emergence of new fields in genomics that complement metagenomics
3.1.2 Market restraint analysis
3.1.2.1 Limited accessibility to computation and different analytic tools
3.1.2.2 High overall cost of metagenomics
3.2 Penetration & Growth Prospect Mapping for Application, 2017
3.3 Metagenomics - Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.4 Industry Analysis - Porter's
Chapter 4 Metagenomics Market Categorization: Product Estimates & Trend Analysis
4.1 Global Metagenomics Market: Product Movement Analysis, 2017 & 2025
4.2 Kits & Reagents
4.3 Sequencing & Data Analytics Services
4.4 Others
Chapter 5 Metagenomics Market Categorization: Technology Estimates & Trend Analysis
5.1 Global Metagenomics Market: Technology Movement Analysis, 2017 & 2025
5.2 Sequencing Driven Metagenomics
5.3 Function Driven Metagenomics
Chapter 6 Metagenomics Market Categorization: Application Estimates & Trend Analysis
6.1 Global Metagenomics Market: Application Movement Analysis, 2017 & 2025
6.2 Environmental
6.3 Human Health
6.4 Others
Chapter 7 Metagenomics Market Categorization: Regional Estimates & Trend Analysis, by Product, Technology & Applications
Chapter 8 Competitive Landscape
- QIAGEN
- F. Hoffmann-La Roche Ltd
- Illumina, Inc.
- Novogene Corporation
- PerkinElmer Inc.
- Bio-Rad Laboratories
- Thermo Fisher Scientific, Inc.
- Merck KGaA
- Agilent Technologies
- Promega Corporation
- Luminex Corporation
- Oxford Gene Technology, Inc.
- TAKARA BIO INC.
- Danaher
- ELITechGroup
- AutoGenomics
- Biocartis Group NV
- IntegraGen.
- ChunLab, Inc.
- uBiome, Inc.
For more information about this report visit https://www.researchandmarkets.com/research/mhb7tw/global?w=5
Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article